-

Komodo Health Appoints Paul Thomas SVP of Finance and Acting CFO

SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the Evidentiary Standard for real-world data and healthcare analytics, today announced the appointment of Paul Thomas as Senior Vice President of Finance and Acting Chief Financial Officer. In this role, Thomas will oversee all aspects of Komodo Health's financial operations and strategy while serving on the company's executive leadership team.

"Paul's ability to drive operational excellence while focusing on long-term value creation makes him the ideal leader to strengthen our financial foundation as we pursue our mission of reducing the burden of disease." Arif Nathoo, MD, CEO and Co-Founder

Share

Thomas brings over 20 years of private and public corporate finance and investment research experience to Komodo Health. Since joining Komodo Health last year, Thomas has significantly strengthened the company's financial infrastructure and strategic capabilities, positioning the organization for continued growth and operational excellence in the evolving healthcare technology landscape.

"Paul's financial acumen and strategic leadership have already made a significant impact on Komodo's growth trajectory," said Arif Nathoo, MD, CEO and Co-Founder of Komodo Health. "His ability to drive operational excellence while focusing on long-term value creation makes him the ideal leader to strengthen our financial foundation as we pursue our mission of reducing the burden of disease."

Prior to joining Komodo Health, Thomas led Strategic Finance and Investor Relations at Talkdesk and played a key role in taking Sumo Logic public in September 2020. He began his career as a semiconductor engineer working at leading manufacturers including Intel Corporation, and later moved into finance, working at Merrill Lynch, Bank of America, and Goldman Sachs.

"At Komodo, we strive to empower healthcare and Life Sciences organizations with comprehensive, patient-centric data insights and an AI-powered platform that delivers immediate value so they can improve patient outcomes," said Thomas. "Strong financial strategy is critical to our execution, and I'm excited to build on the momentum we've established and help drive Komodo's next phase of growth."

About Komodo Health

Komodo is a healthcare insights and technology company that delivers the Evidentiary Standard for real-world data and analytics. By pairing the industry’s most complete, unbiased view of patient encounters with AI-enabled and fit-for-purpose software, Komodo connects the dots between patient journeys and large-scale health outcomes. Across Life Sciences, payers, providers, and developers, Komodo delivers a velocity advantage by helping its customers accurately and efficiently access patient-centric insights at scale to drive faster decision-making, optimize workflows, close gaps in care, and help reduce the burden of disease. For more information, visit Komodohealth.com.

Contacts

Rowena Kelley
858.255.1651
media@komodohealth.com

Komodo Health


Release Versions

Contacts

Rowena Kelley
858.255.1651
media@komodohealth.com

Social Media Profiles
More News From Komodo Health

Komodo Health’s MapLab™ Enterprise Transforms Healthcare Analytics With Immediate Time to Value Across Life Sciences Organizations

SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health announced the launch of MapLab Enterprise, a powerful, full-stack analytics platform that transforms how Healthcare and Life Sciences organizations generate and operationalize healthcare insights. Continuing along the path that Komodo has charted in delivering AI-enabled insights, MapLab Enterprise empowers diverse teams — from data scientists to executives — to collaborate seamlessly, accelerate time to insight, and make faster, more confident deci...

Komodo Health's Real-World Evidence Platform Drives 31 Patient Journey Research Studies at ISPOR 2025

MONTREAL--(BUSINESS WIRE)--Komodo Health today announced that its healthcare intelligence platform enabled 31 research studies being presented at the 2025 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) global conference. These include three studies led by Komodo researchers and 27 collaborative studies with academic institutions, Life Sciences companies, and healthcare organizations. "The volume and diversity of research powered by our healthcare insights underscore t...

Komodo Health Partners with Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry

NEW YORK--(BUSINESS WIRE)--Komodo Health, the Evidentiary Standard for real-world data and healthcare analytics, today announced a partnership with Nasdaq Data to provide hedge funds, private equity, and venture capital firms with an in-depth view into the pharmaceutical and U.S. healthcare industries through the Nasdaq Medical Claims Insights (NMCI) dataset. Sourced from Komodo’s Healthcare Map, the most comprehensive source of real-world data for understanding payer and provider trends, disea...
Back to Newsroom